Biomed Diagnostics, Inc. today announces the release of P4 Rapid to the U.S. dairy market. P4 Rapid represents the easiest way for dairy herd owners, managers, and veterinary technicians to quickly and accurately identify the fertility status of any healthy cow-in 5 minutes.
The desire for immediate identification of fertility status in order to properly time the use of Artificial Insemination (AI) has long been a goal of herd owners around the world. U.S. AI pregnancy success rates average only around 30% due to the lower effectiveness of current estrus identification methods. P4 Rapid's intuitive cow-side, lateral flow design requires no special skills or training to use and delivers accurate, near instant results through a simple visual reaction. P4 Rapid represents a significant milestone and a dramatic paradigm shift from the slow and expensive testing used in today's dairy breeding community.
"The U.S. dairy herd owner is hamstrung by the limited accuracy of today's estrus detection technologies, which is limiting their ability to increase insemination rates," states Biomed Diagnostics Marketing and P4 Rapid Product Manager, Eli Beard. "That inaccuracy results in wasted inseminations, reduced milk production, and increased overhead costs." He continued, "In regular use, P4 frees up so many resources in the workflow of U.S. dairy operations, savings in direct insemination costs may end up secondary to savings yielded in direct labor and losses from high cost technologies that-without a validator like P4 Rapid-produce only semi-reliable estrus indicators for herd owners."
Working in partnership with Ridgeway Science, a division of Ridgeway Research, Biomed Diagnostics will provide exclusive sales and technical support for P4 Rapid to the U.S. dairy and genetics markets. Ridgeway Science Executive Director Maggie Fisher offered, "The relationship between Ridgeway Science and Biomed Diagnostics offers a symbiosis rarely found in the veterinary diagnostics community." Ms. Fisher continued by adding, "Being in partnership with Biomed gives Ridgeway a connection to the reputation and relationships Biomed has built over the years, that otherwise might be out of our effective reach. Biomed's excellent market relationship allows us to quickly deliver the value of P4 Rapid so badly needed in the burgeoning U.S. dairy herd."
When asked what drew Biomed Diagnostics, Inc. to the bucolic village of St. Briavels, UK, Biomed CEO Amir Kanji replied, "One of the largest productivity gaps in U.S. dairy production is in the use of estrus detection devices. Dairy farmers are often left to guess whether or not to inseminate. P4 Rapid eliminates the guesswork of insemination as well as brings cows back into production much faster than other methods. It was a simple decision to reach out to Ridgeway once we learned how easy and effective a solution they had formulated."
P4 Rapid's initial release will be to a select group of U.S. genetics producers who will quickly begin to deliver value in both how and when the producers use the high quality genetics supplies and service they provide. U.S. wide release is expected shortly thereafter.
Ridgeway Science, a division of Ridgeway Research, located in St. Briavels Gloucestershire, UK est. 1986, provides products and services to veterinary productivity in the form of pharmaceutical testing and veterinary diagnostic research and development. In business since 1986, their products are used throughout Europe, Asia, the Near East, and India.
Biomed Diagnostics, Inc. est. 1989 in White City, Oregon is a boutique designer and manufacturer of FDA listed and cleared human devices, as well as veterinary, and environmental test kits sold under the trade names InPouch™ and InTray™, sold through distribution around the world. Biomed has served the U.S. beef production community with the globally accepted InPouch™ TF Bovine diagnostic kit for USDA overseen organism Tritrichomonas foetus.
2.21.2016
